Page last updated: 2024-08-17

androstenedione and eflornithine

androstenedione has been researched along with eflornithine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Castells, MT; Cremades, A; López-Contreras, AJ; López-García, C; Marín, F; Peñafiel, R; Schreiber, F	1
Azziz, R; Gavrilova-Jordan, L; Lizneva, D; Walker, W	1

Reviews

1 review(s) available for androstenedione and eflornithine

Article	Year
Androgen excess: Investigations and management. Best practice & research. Clinical obstetrics & gynaecology, 2016, Volume: 37 Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Androstenedione; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone Sulfate; Eflornithine; Female; Hair Removal; Hirsutism; Humans; Hyperandrogenism; Ornithine Decarboxylase Inhibitors; Polycystic Ovary Syndrome; Testosterone	2016

Article

Year

Androgen excess: Investigations and management.

Best practice & research. Clinical obstetrics & gynaecology, 2016, Volume: 37

Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Androstenedione; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone Sulfate; Eflornithine; Female; Hair Removal; Hirsutism; Humans; Hyperandrogenism; Ornithine Decarboxylase Inhibitors; Polycystic Ovary Syndrome; Testosterone

2016

Other Studies

2 other study(ies) available for androstenedione and eflornithine

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Molecular and morphological changes in placenta and embryo development associated with the inhibition of polyamine synthesis during midpregnancy in mice. Endocrinology, 2008, Volume: 149, Issue:10 Topics: Androstenedione; Animals; Decidua; Eflornithine; Embryonic Development; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Gestational Age; Hematopoiesis; Mice; Mice, Inbred Strains; Ornithine Decarboxylase; Polyamines; Pregnancy; Progesterone; Steroids; Yolk Sac	2008

Article

Year

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008

Molecular and morphological changes in placenta and embryo development associated with the inhibition of polyamine synthesis during midpregnancy in mice.

Endocrinology, 2008, Volume: 149, Issue:10

Topics: Androstenedione; Animals; Decidua; Eflornithine; Embryonic Development; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Gestational Age; Hematopoiesis; Mice; Mice, Inbred Strains; Ornithine Decarboxylase; Polyamines; Pregnancy; Progesterone; Steroids; Yolk Sac

2008